<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Agarwal R</submitter><funding>NIAID NIH HHS</funding><pagination>102134</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12147901</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(5)</volume><pubmed_abstract>Chikungunya virus (CHIKV) is a mosquito-borne virus that can cause chronic chikungunya virus disease (CHIKVD), which is characterized by persistent incapacitating arthralgia. Despite recurring CHIKV outbreaks and recent approval of a vaccine, the breadth and target of T cell responses in CHIKVD remain largely understudied. Here, we tested peripheral blood mononuclear cells (PBMCs) collected from CHIKV-infected individuals against overlapping peptide pools sequentially spanning the entire CHIKV proteome. We detected robust CHIKV-specific CD4&lt;sup>+&lt;/sup>, but not CD8&lt;sup>+&lt;/sup>, T cell responses in infected individuals. Individuals with chronic arthralgia displayed significantly higher CD4&lt;sup>+&lt;/sup> T cell responses against nsP1, nsP2, and E2 proteins and exhibited a significantly lower T</pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>Chikungunya virus-specific CD4&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T cells are associated with chronic chikungunya viral arthritic disease in humans.</pubmed_title><pmcid>PMC12147901</pmcid><funding_grant_id>75N93019C00065</funding_grant_id><funding_grant_id>U24 AI152170</funding_grant_id><pubmed_authors>Sette A</pubmed_authors><pubmed_authors>Agarwal R</pubmed_authors><pubmed_authors>Falconar AK</pubmed_authors><pubmed_authors>Premkumar L</pubmed_authors><pubmed_authors>Cortes FH</pubmed_authors><pubmed_authors>Galvez RI</pubmed_authors><pubmed_authors>Grifoni A</pubmed_authors><pubmed_authors>Heise MT</pubmed_authors><pubmed_authors>Weiskopf D</pubmed_authors><pubmed_authors>Castillo IN</pubmed_authors><pubmed_authors>Romero-Vivas CM</pubmed_authors><pubmed_authors>Villalpando J</pubmed_authors><pubmed_authors>Chang J</pubmed_authors><pubmed_authors>Ha C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chikungunya virus-specific CD4&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T cells are associated with chronic chikungunya viral arthritic disease in humans.</name><description>Chikungunya virus (CHIKV) is a mosquito-borne virus that can cause chronic chikungunya virus disease (CHIKVD), which is characterized by persistent incapacitating arthralgia. Despite recurring CHIKV outbreaks and recent approval of a vaccine, the breadth and target of T cell responses in CHIKVD remain largely understudied. Here, we tested peripheral blood mononuclear cells (PBMCs) collected from CHIKV-infected individuals against overlapping peptide pools sequentially spanning the entire CHIKV proteome. We detected robust CHIKV-specific CD4&lt;sup>+&lt;/sup>, but not CD8&lt;sup>+&lt;/sup>, T cell responses in infected individuals. Individuals with chronic arthralgia displayed significantly higher CD4&lt;sup>+&lt;/sup> T cell responses against nsP1, nsP2, and E2 proteins and exhibited a significantly lower T</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-04-25T03:22:08.702Z</modification><creation>2026-04-25T03:20:34.494Z</creation></dates><accession>S-EPMC12147901</accession><cross_references><pubmed>40398392</pubmed><doi>10.1016/j.xcrm.2025.102134</doi></cross_references></HashMap>